Search

Author/Creator Aggarwal, Charu

21. Increased rate of recurrence and high rate of salvage in patients with human papillomavirus–associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy. Issue 4 (16th December 2020)

Authors:
Carey, Ryan M.; Shimunov, David; Weinstein, Gregory S.; Cannady, Steven B.; Lukens, John N.; Lin, Alexander; Swisher‐McClure, Samuel; Bauml, Joshua M.; Aggarwal, Charu; Cohen, Roger B.; Newman, Jason G.; Chalian, Ara A.; Rassekh, Christopher H.; Basu, Devraj; O'Malley, Bert W.; Rajasekaran, Karth...
Journal:
Head & neck
Issue:
Volume 43:Issue 4(2021)
Page Start:
1128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. Molecular Imaging to Identify Tumor Recurrence following Chemoradiation in a Hostile Surgical Environment. Issue 1 (1st January 2015)

Authors:
Okusanya, Olugbenga T.; Deshpande, Charuhas; Barbosa, Eduardo M.; Aggarwal, Charu; Simone, Charles B.; Jiang, Jack; Judy, Ryan; DeJesus, Elizabeth; Albelda, Steve; Nie, Shuming; Low, Philip S.; Singhal, Sunil
Journal:
Molecular imaging
Issue:
Volume 14, Issue 1(2015)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery. (July 2021)

Authors:
Yver, Christina M.; Shimunov, David; Weinstein, Gregory S.; Rajasekaran, Karthik; Cannady, Steven B.; Lukens, John N.; Lin, Alexander; Swisher-McClure, Samuel; Cohen, Roger B.; Aggarwal, Charu; Bauml, Joshua M.; Loevner, Laurie A.; Newman, Jason G.; Chalian, Ara A.; Rassekh, Christopher H.; Basu,...
Journal:
Oral oncology
Issue:
Volume 118(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

28. Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial. (28th August 2020)

Authors:
Steffen McLouth, Laurie E.; Zhao, Fengmin; Owonikoko, Taofeek K.; Feliciano, Josephine L.; Mohindra, Nisha A.; Dahlberg, Suzanne E.; Wade, James L.; Srkalovic, Gordan; Lash, Bradley W.; Leach, Joseph W.; Leal, Ticiana A.; Aggarwal, Charu; Cella, David; Ramalingam, Suresh S.; Wagner, Lynne I.
Journal:
Cancer medicine
Issue:
Volume 9:Number 20(2020)
Page Start:
7511
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

29. Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial. (28th August 2020)

Authors:
Steffen McLouth, Laurie E.; Zhao, Fengmin; Owonikoko, Taofeek K.; Feliciano, Josephine L.; Mohindra, Nisha A.; Dahlberg, Suzanne E.; Wade, James L.; Srkalovic, Gordan; Lash, Bradley W.; Leach, Joseph W.; Leal, Ticiana A.; Aggarwal, Charu; Cella, David; Ramalingam, Suresh S.; Wagner, Lynne I.
Journal:
Cancer medicine
Issue:
Volume 9:Number 20(2020)
Page Start:
7511
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

30. Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study. Issue 4 (April 2019)

Authors:
Leighl, Natasha B; Hellmann, Matthew D; Hui, Rina; Carcereny, Enric; Felip, Enriqueta; Ahn, Myung-Ju; Eder, Joseph Paul; Balmanoukian, Ani S; Aggarwal, Charu; Horn, Leora; Patnaik, Amita; Gubens, Matthew; Ramalingam, Suresh S; Lubiniecki, Gregory M; Zhang, Jin; Piperdi, Bilal; Garon, Edward B
Journal:
Lancet
Issue:
Volume 7:Issue 4(2019)
Page Start:
347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗